Another advantage of amyloid PET, the marker of aggre- gated Aβ, is the ability to monitor response to anti-amyloid therapies. Fluid biomarkers, being sensitive to dynamic changes of amyloidopathy, are not rec
Leqembi is an antibody that reduces the number of beta-amyloid plaques in people with early-stage Alzheimer's. The drug helps slow down memory loss.